Baroreflex activation therapy in heart failure patients with reduced ejection fraction: a long-term follow up

被引:0
作者
Wang, D. [1 ]
Mueller-Leisse, J. [1 ]
Hillmann, H. A. K. [1 ]
Eiringhaus, J. [1 ]
Berliner, D. [1 ]
Karfoul, N. [1 ]
Schmitto, J. D. [2 ]
Ruhparwar, A. [2 ]
Bauersachs, J. [1 ]
Duncker, D. [1 ]
机构
[1] Hannover Med Sch, Cardiol & Angiol, Hannover, Germany
[2] Hannover Med Sch, Cardiothorac Transplantat & Vasc Surg, Hannover, Germany
关键词
D O I
10.1093/eurheartj/ehae666.1141
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Updates on Baroreflex Activation Therapy and Vagus Nerve Stimulation for Treatment of Heart Failure With Reduced Ejection Fraction
    Babar, Natasha
    Giedrimiene, Dalia
    CARDIOLOGY RESEARCH, 2022, 13 (01) : 11 - 17
  • [32] Long-term follow-up of patients with heart failure with preserved left ventricular ejection fraction: prognostic determinants
    de Isla, L. Perez
    Zamorano, J.
    Contreras, L.
    Almeria, C.
    Rodrigo, J. L.
    Aubele, A.
    Quezada, M.
    Macaya, C.
    EUROPEAN HEART JOURNAL, 2005, 26 : 380 - 380
  • [33] Heart Failure With Recovered Ejection Fraction in Patients With Nonischemic Cardiomyopathy: Characteristics, Outcomes, and Long-term Follow-up
    Hammer, Yoav
    Yosef, Matheos
    Khalatbari, Shokoufeh
    Aaronson, Keith d.
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (12) : 1593 - 1602
  • [34] Safety and efficacy of baroreflex activation therapy for heart failure with reduced ejection fraction: a rapid systematic review
    Schmidt, Rodrigo
    Rodrigues, Clarissa Garcia
    Schmidt, Kelen Heinrich
    Costa Irigoyen, Maria Claudia
    ESC HEART FAILURE, 2020, 7 (01): : 3 - 14
  • [35] Cardiopulmonary function during exercise in heart failure with reduced ejection fraction following baroreflex activation therapy
    Nottebohm, Pia, I
    Dumitrescu, Daniel
    Hamacher, Stefanie
    Hohmann, Christopher
    Madershahian, Navid
    Baldus, Stephan
    Reuter, Hannes
    Halbach, Marcel
    THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE, 2022, 16
  • [36] Long-term changes in renal function and perfusion in heart failure patients with reduced ejection fraction
    Schroten, Nicolas F.
    Damman, Kevin
    Valente, Mattia A. E.
    Smilde, Tom D.
    van Veldhuisen, Dirk J.
    Navis, Gerjan
    Gaillard, Carlo A.
    Voors, Adriaan A.
    Hillege, Hans L.
    CLINICAL RESEARCH IN CARDIOLOGY, 2016, 105 (01) : 10 - 16
  • [37] The effects of Digoxin use on long-term prognosis in patients with heart failure with reduced ejection fraction
    Ozyildirim, S.
    Barman, H. A.
    Dogan, O.
    Atici, A.
    Mirzayev, K.
    Ebeoglu, A. O.
    Yumuk, M. T.
    Ikitimur, B.
    Dogan, S. M.
    Enar, R.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (15) : 7226 - 7234
  • [38] Long-term changes in renal function and perfusion in heart failure patients with reduced ejection fraction
    Nicolas F. Schroten
    Kevin Damman
    Mattia A. E. Valente
    Tom D. Smilde
    Dirk J. van Veldhuisen
    Gerjan Navis
    Carlo A. Gaillard
    Adriaan A. Voors
    Hans L. Hillege
    Clinical Research in Cardiology, 2016, 105 : 10 - 16
  • [39] Baroreceptor activation therapy in heart failure with reduced ejection fraction
    Hohmann, Stephan
    Bauersachs, Johann
    Veltmann, Christian
    KARDIOLOGE, 2020, 14 (06): : 551 - 560
  • [40] CSA Is Not Beneficial Long Term in Heart Failure Patients with Reduced Ejection Fraction
    Oldenburg, Olaf
    Coats, Andrew
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 227 : 474 - 477